Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion type Assertion NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_head.
- NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion description "[The experience of the past 3 years, since the first case of leukemia was reported in a child cured of X-linked severe combined immunodeficiency (X-SCID) by gene therapy, indicates that the potential genotoxicity of retroviral integration in hematopoietic cells will remain a consideration in evaluating the relative risks versus benefits of gene therapy for specific blood disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion evidence source_evidence_literature NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion SIO_000772 16624621 NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion wasDerivedFrom befree-20150227 NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.
- NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_assertion wasGeneratedBy ECO_0000203 NP896832.RAnfIo9nyldVNRboQQEUIWny5Dr-L109FSW853f_H6x6s130_provenance.